Literature DB >> 1200727

Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings.

D A Sears, J N George, M S Gold.   

Abstract

Transient pure red blood cell aplasia was verified during the course of viral hepatitis in two siblings whose illnesses occurred four years apart. The duration and course of the anemia was very similar in the two subjects, and in both the hepatitis progressed to a chronic active form. Autoimmune phenomena were prominent in one patient and suggested in the other, but a cytotoxic antibody to erythroblasts could not be demonstrated in the one patient in whom it was sought. The unique occurrence of such a syndrome in siblings, widely separated in time, suggests the possibility of a genetic predisposition governing the unusual response to a common illness.

Entities:  

Mesh:

Year:  1975        PMID: 1200727

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Pure red cell aplasia with an inhibitor to erythropoiesis.

Authors:  A M Seidenfeld; J Owen; J F Prchal; M F Glynn
Journal:  Can Med Assoc J       Date:  1979-07-21       Impact factor: 8.262

2.  Phenytoin-associated reversible red cell aplasia.

Authors:  K I Pritchard; I C Quirt; W J Simpson; J F Fleming
Journal:  Can Med Assoc J       Date:  1979-12-08       Impact factor: 8.262

Review 3.  Severe acute hepatitis A associated with acute pure red cell aplasia.

Authors:  S Tomida; Y Matsuzaki; M Nishi; T Ikegami; T Chiba; M Abei; N Tanaka; T Osuga; Y Sato; T Abe
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

4.  Marrow hypoplasia with splenomegaly in adolescence.

Authors:  J H Robertson; P Burnside; D C Salmon
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

5.  Hemolytic Anemia after Acute Hepatitis B Virus Infection: A Case Report and Systematic Review.

Authors:  Takahiro Suzuki; Takeshi Okamoto; Fujimi Kawai; Shuhei Okuyama; Katsuyuki Fukuda
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.